Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction

OBJECTIVE: This study was conducted to investigate the efficacy and safety of using a concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of the gastroesophageal junction. METHODS: Seventy-six patients having resectable adenocarcinoma at the gastroesophageal junction (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qun, Li, Yong, Wang, Jun, Zhang, Jun, Qiao, Xueying, Tan, Bibo, Tian, Yuan, Shi, Gaofeng, Xu, Qian, Li, Ruxun, Liu, Yueping, Yang, Peigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Journal of the Medical Sciences 2015
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450970/
https://www.ncbi.nlm.nih.gov/pubmed/25996101
http://dx.doi.org/10.1097/MAJ.0000000000000476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450970/
https://www.ncbi.nlm.nih.gov/pubmed/25996101
http://dx.doi.org/10.1097/MAJ.0000000000000476

Ejemplares similares